Healio
SearchLoading
Healio
SearchLoading
Author headshot

Elizabeth Volkmann, MD, MS

Volkmann is associate professor and director of the UCLA Scleroderma Program and co-director of the CTD-ILD Program at University of California, Los Angeles.
Choose a Section

Most recent by Elizabeth Volkmann, MD, MS

SPONSORED CONTENT
February 13, 2024
3 min read
Save

Nintedanib slows symptom worsening in progressive pulmonary fibrosis

Among patients with progressive pulmonary fibrosis, taking nintedanib for 52 weeks lowered the degree of worsened dyspnea, fatigue and cough compared with placebo, according to results published in European Respiratory Journal.